Cross-sectional nationwide mixed-methods population-based study of living conditions, and identification of sexual and fertility profiles among young women after breast cancer in France: the Candy study protocol.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
28 09 2022
Historique:
entrez: 28 9 2022
pubmed: 29 9 2022
medline: 1 10 2022
Statut: epublish

Résumé

At the end of the treatment, many young breast cancer (BC) survivors face difficulties related to fertility and sexuality, mainly due to the side effects of treatment. Integrating patient needs into medical decisions is becoming increasingly essential for high quality care. To this end, there is a compelling need to elicit patients' perspectives through qualitative studies, to understand their experiences and needs in the aftermath of cancer. We aim to: (1) identify clinical, social and economic determinants of sexuality and fertility, and describe other living conditions of young BC survivors in France; and (2) explore young women's experience after BC in relation to clinical and information needs about fertility preservation and sexual health. This is a mixed-methods, cross-sectional, population-based study. In the quantitative component, women diagnosed with non-metastatic BC between 2009 and 2016 and aged 40 years or younger at diagnosis will be identified through the French network of cancer registries (FRANCIM). Participants will complete self-report questionnaires including standardised measures of sexuality, health-related quality of life (HRQoL), anxiety, depression, social deprivation and social support. Fertility and professional reintegration issues will also be assessed. Sexuality profiles will be identified by ascending hierarchical classification and fertility profiles will be identified by latent class models. Determinants of sexuality, fertility and HRQoL will be identified using a mixed regression model. Subsequently, semistructured interviews will be performed with a sample of 30 women who participated in the quantitative study. Interviews will be recorded, transcribed synthetically and content analysis will be performed, with the aid of NVivo software. This study will be performed in accordance with the declaration of Helsinki. The protocol was approved in October 2020 by the Committee for the Protection of Persons North-West III (20.07.16.44445) and by the French national data protection authority (CNIL-MR003 No1989764-v0).The results of this project will be communicated to the scientific community through publications in international scientific peer-reviewed journals and communications to national and international congresses. Popularised results will also be provided to patient associations. The results of Candy project will also be published on the website of the sponsor, www.cgfl.fr.

Identifiants

pubmed: 36171047
pii: bmjopen-2021-056834
doi: 10.1136/bmjopen-2021-056834
pmc: PMC9528580
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e056834

Investigateurs

Simona Bara (S)
Bénédicte Lapotre-Ledoux (B)
Sandrine Plouvier (S)
Karima Hammas (K)
Tienhan Sandrine Dabakuyo-Yonli (TS)
Pascale Grosclaude (P)
Laetitia Daubisse-Marliac (L)
Brigitte Tretarre (B)
Florence Molinie (F)
Anne Cowppli-Bony (A)
Anne-Sophie Woronoff (AS)
Gaëlle Coureau (G)
Marc Colonna (M)
Patricia Delafosse (P)
Michel Velten (M)
Tania d'Almeida (T)
Anne-Valérie Guizard (AV)
Gautier Defossez (G)
Jacqueline Deloumeaux (J)
Clarisse Joachim-Contaret (C)
Juliette Plenet (J)
L Manuella Imounga-Desroziers (L)

Informations de copyright

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Eur J Oncol Nurs. 2012 Apr;16(2):124-30
pubmed: 21601525
BMJ Open. 2015 Mar 24;5(3):e005971
pubmed: 25805526
PLoS One. 2018 Aug 31;13(8):e0203151
pubmed: 30169506
Lancet Oncol. 2008 Aug;9(8):730-56
pubmed: 18639491
Psychol Rep. 2005 Aug;97(1):195-202
pubmed: 16279325
Hum Reprod. 2018 Jul 1;33(7):1281-1290
pubmed: 29912328
Psychol Health. 2014;29(6):632-50
pubmed: 24404999
Psychooncology. 2019 Jan;28(1):195-197
pubmed: 30225895
J Clin Oncol. 1996 Oct;14(10):2756-68
pubmed: 8874337
Qual Life Res. 2016 Aug;25(8):1981-90
pubmed: 26914102
Patient Educ Couns. 2019 Mar;102(3):436-442
pubmed: 30314828
Qual Life Res. 2014 Sep;23(7):2079-87
pubmed: 24585184
J Cancer Surviv. 2017 Aug;11(4):431-437
pubmed: 28130711
Eur J Cancer. 2010 Oct;46(15):2726-38
pubmed: 20674333
Arch Intern Med. 1998 Sep 14;158(16):1789-95
pubmed: 9738608
Ann Surg Oncol. 2016 Oct;23(10):3175-81
pubmed: 27334218
Cancers (Basel). 2020 Jun 12;12(6):
pubmed: 32545701
J Psychosoc Oncol. 2016 Sep-Oct;34(5):413-31
pubmed: 27295387
Cancer Nurs. 2011 Jan-Feb;34(1):32-40
pubmed: 20697269
J Natl Cancer Inst. 1993 Mar 3;85(5):365-76
pubmed: 8433390
Int J Cancer. 2018 May 15;142(10):1994-2002
pubmed: 29266267
Ann Agric Environ Med. 2019 Jun 17;26(2):379-384
pubmed: 31232075
Psychooncology. 2018 Dec;27(12):2770-2777
pubmed: 30203884
Acta Oncol. 2017 Feb;56(2):174-182
pubmed: 28093023
Breast J. 2009 Sep-Oct;15(5):500-4
pubmed: 19614908
Maturitas. 2015 Jul;81(3):362-70
pubmed: 25911244
Fertil Steril. 2016 Dec;106(7):1763-1771.e1
pubmed: 27678034
Reprod Health. 2018 Jan 05;15(1):2
pubmed: 29304873
J Clin Epidemiol. 1998 Nov;51(11):1171-8
pubmed: 9817135
Patient Educ Couns. 2018 Feb;101(2):318-323
pubmed: 28870441
Psychooncology. 2010 Oct;19(10):1112-5
pubmed: 19918959
CA Cancer J Clin. 2017 Mar;67(2):93-99
pubmed: 28094848
J Sex Marital Ther. 2000 Apr-Jun;26(2):191-208
pubmed: 10782451
Clin Exp Reprod Med. 2017 Dec;44(4):181-186
pubmed: 29376014
Fertil Steril. 2010 Nov;94(6):2396-8
pubmed: 20447625
Lancet. 1985 Dec 21-28;2(8469-70):1425-6
pubmed: 2867417
Reprod Biomed Online. 2022 Jun;44(6):1031-1044
pubmed: 35525718
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Lancet Oncol. 2016 Oct;17(10):1354-1356
pubmed: 27733259
Oncologist. 2019 Jul;24(7):e490-e500
pubmed: 30578310
J Clin Nurs. 2013 Apr;22(7-8):1044-52
pubmed: 23480500
Breast Cancer Manag. 2015;4(1):53-64
pubmed: 25733982

Auteurs

Emerline L F Assogba (ELF)

Breast and Gynaecologic Cancer Registry of Côte d'Or, Epidemiology and Quality of Life Research Unit, Georges François Leclerc Comprehensive Cancer Centre - UNICANCER, Dijon, Bourgogne-Franche-Comté, France.
Lipids, Nutrition, Cancer Research Center, French National Institute of Health and Medical Research (Institut National de la Santé et de la Recherche Médicale [INSERM]) U1231, Dijon, Bourgogne-Franche-Comté, France.

Agnès Dumas (A)

Clinical Epidemiology and Economic Evaluation Applied to Vulnerable Populations (Epidémiologie Clinique et Évaluation Économique appliquée aux Populations Vulnérables [ECEVE])-INSERM UMR 1123, University of Paris, Paris, Île-de-France, France.

Anne-Sophie Woronoff (AS)

Cancer Registry of Doubs, Besançon Regional University Hospital Centre, Besançon, Bourgogne-Franche-Comté, France.
EA3181, Burgundy Franche-Comté University, Besançon, Bourgogne-Franche-Comté, France.

Caroline Mollévi (C)

Biometrics Unit, Montpellier Cancer Research Institute, Montpellier, Languedoc-Roussillon-Midi-Pyrénées, France.
University of Montpellier, Montpellier, Languedoc-Roussillon-Midi-Pyrénées, France.

Charles Coutant (C)

Department of Surgical Oncology, Georges François Leclerc Comprehensive Cancer Centre - UNICANCER, Dijon, Bourgogne-Franche-Comté, France.
Faculty of Medicine and Pharmacy, Burgundy Franche-Comté University, Dijon, Bourgogne-Franche-Comté, France.

Sylvain Ladoire (S)

Medical Oncology Unit, Georges François Leclerc Comprehensive Cancer Centre - UNICANCER, Dijon, Bourgogne-Franche-Comté, France.
Chemotherapy and Immune Response Team, Lipides Nutrition Cancer, Dijon, Bourgogne-Franche-Comté, France.

Isabelle Desmoulins (I)

Medical Oncology Unit, Georges François Leclerc Comprehensive Cancer Centre - UNICANCER, Dijon, Bourgogne-Franche-Comté, France.

Tienhan Sandrine Dabakuyo-Yonli (TS)

Breast and Gynaecologic Cancer Registry of Côte d'Or, Epidemiology and Quality of Life Research Unit, Georges François Leclerc Comprehensive Cancer Centre - UNICANCER, Dijon, Bourgogne-Franche-Comté, France SDabakuyo@cgfl.fr.
Lipids, Nutrition, Cancer Research Center, French National Institute of Health and Medical Research (Institut National de la Santé et de la Recherche Médicale [INSERM]) U1231, Dijon, Bourgogne-Franche-Comté, France.
National Quality of Life and Cancer Clinical Research Platform, Dijon, Bourgogne-Franche-Comté, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH